(Q33329577)

English

Platelet glycoprotein IIb/IIIa antagonists. What are the relevant issues concerning their pharmacology and clinical use?

scientific article

In more languages

edit

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

25 July 2017

1 reference

Europe PubMed Central

title

Platelet glycoprotein IIb/IIIa antagonists. What are the relevant issues concerning their pharmacology and clinical use? (English)

1 reference

stated in

Europe PubMed Central

25 July 2017

1 reference

Scarborough RM

1

1 reference

stated in

Europe PubMed Central

PubMed ID

10421606

retrieved

25 July 2017

Kleiman NS

series ordinal

2

1 reference

stated in

Europe PubMed Central

PubMed ID

10421606

retrieved

25 July 2017

Phillips DR

series ordinal

3

1 reference

stated in

Europe PubMed Central

PubMed ID

10421606

retrieved

25 July 2017

language of work or name

English

0 references

publication date

1 July 1999

1 reference

stated in

Europe PubMed Central

25 July 2017

1 reference

Europe PubMed Central

25 July 2017

100

1 reference

stated in

Europe PubMed Central

25 July 2017

437-444

1 reference

stated in

Europe PubMed Central

25 July 2017

4

1 reference

stated in

Europe PubMed Central

PubMed ID

10421606

retrieved

25 July 2017

Identifiers

DOI

10.1161/01.CIR.100.4.437

1 reference

stated in

Europe PubMed Central

25 July 2017

1 reference

Europe PubMed Central

PubMed ID

10421606

retrieved

25 July 2017

(Q33329577)

Platelet glycoprotein IIb/IIIa antagonists. What are the relevant issues concerning their pharmacology and clinical use?

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)